Liwei Chen

992 total citations
38 papers, 730 citations indexed

About

Liwei Chen is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Liwei Chen has authored 38 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Liwei Chen's work include Protein Tyrosine Phosphatases (7 papers), Galectins and Cancer Biology (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Liwei Chen is often cited by papers focused on Protein Tyrosine Phosphatases (7 papers), Galectins and Cancer Biology (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Liwei Chen collaborates with scholars based in United States, China and Japan. Liwei Chen's co-authors include Jie Wu, Harshani R. Lawrence, Saı̈d M. Sebti, Nicholas J. Lawrence, Hua Guo, Wayne C. Guida, Yuchao He, Lisha Qi, Ning Zhang and Hui Fu and has published in prestigious journals such as Cancer Research, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Liwei Chen

37 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liwei Chen United States 15 429 239 142 140 121 38 730
Michela Guardascione Italy 16 331 0.8× 336 1.4× 195 1.4× 85 0.6× 209 1.7× 37 847
Sarah Sarkar United States 12 486 1.1× 356 1.5× 137 1.0× 69 0.5× 268 2.2× 13 980
Chengguang Zhao China 15 285 0.7× 147 0.6× 153 1.1× 65 0.5× 106 0.9× 52 609
Xisha Chen China 13 544 1.3× 217 0.9× 90 0.6× 107 0.8× 189 1.6× 21 800
Eun‐Taik Jeong South Korea 16 408 1.0× 163 0.7× 232 1.6× 56 0.4× 180 1.5× 42 812
Ruei‐Nian Li Taiwan 15 348 0.8× 115 0.5× 126 0.9× 138 1.0× 188 1.6× 43 723
Petra C. Buchanan United States 4 400 0.9× 286 1.2× 261 1.8× 101 0.7× 202 1.7× 4 867
Praveen Kumar Jaiswal India 14 472 1.1× 177 0.7× 116 0.8× 106 0.8× 100 0.8× 33 746
Meng-Ning Wei China 16 512 1.2× 233 1.0× 149 1.0× 55 0.4× 215 1.8× 23 770

Countries citing papers authored by Liwei Chen

Since Specialization
Citations

This map shows the geographic impact of Liwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Chen more than expected).

Fields of papers citing papers by Liwei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Chen. The network helps show where Liwei Chen may publish in the future.

Co-authorship network of co-authors of Liwei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Chen. A scholar is included among the top collaborators of Liwei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Chen. Liwei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiuhua, et al.. (2025). In-situ coaxial temperature monitoring of LPBF melt pool by a compact dual-wavelength thermometry system (CDWTS). Optics and Lasers in Engineering. 194. 109194–109194. 1 indexed citations
2.
Kazi, Aslamuzzaman, Vasantha Kumar M.V., Bogos Agianian, et al.. (2023). Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors. Cancer Research Communications. 3(12). 2623–2639. 10 indexed citations
3.
Goldschmidt, Jerome H., Philip K. Chan, Liwei Chen, et al.. (2023). Real‐world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy. Cancer Medicine. 12(22). 20783–20797. 14 indexed citations
4.
Wang, Mengchao, et al.. (2023). Clinical research progress on BRAF V600E-mutant advanced colorectal cancer. Journal of Cancer Research and Clinical Oncology. 149(17). 16111–16121. 2 indexed citations
5.
He, Yuchao, Wenchen Gong, Yu Wang, et al.. (2023). Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma. International Journal of Biological Sciences. 19(13). 4061–4081. 20 indexed citations
6.
Samlowski, Wolfram E., Nicholas J. Robert, Liwei Chen, et al.. (2022). Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma. Cancer Medicine. 12(3). 2378–2388. 3 indexed citations
8.
Kazi, Aslamuzzaman, Liwei Chen, Shengyan Xiang, et al.. (2021). Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. Clinical Cancer Research. 27(14). 4012–4024. 25 indexed citations
9.
Pressman, Elliot, Liwei Chen, Rahul Mhaskar, et al.. (2021). Eloquence-based reperfusion scoring and its ability to predict post-thrombectomy disability and functional status. Interventional Neuroradiology. 28(5). 538–546. 2 indexed citations
10.
Zhao, Jingwen, Ting Yang, Liwei Chen, et al.. (2021). Bicyclol Alleviates Signs of BDL-Induced Cholestasis by Regulating Bile Acids and Autophagy-Mediated HMGB1/p62/Nrf2 Pathway. Frontiers in Pharmacology. 12. 686502–686502. 10 indexed citations
12.
Chen, Liwei, Mokenge P. Malafa, Pamela J. Hodul, et al.. (2020). Outcomes of Gastric Resection in the Establishment of a Comprehensive Oncologic Robotic Program. Journal of Surgical Research. 252. 30–36. 1 indexed citations
13.
Chen, Liwei, Rahul Mhaskar, Junsung Choi, et al.. (2020). Liver tumor ablation in difficult locations: Microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clinical Imaging. 71. 170–177. 23 indexed citations
14.
Kazi, Aslamuzzaman, Shengyan Xiang, Hua Yang, et al.. (2019). Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors. Clinical Cancer Research. 25(19). 5984–5996. 53 indexed citations
15.
He, Yuchao, Lu Chen, Lisha Qi, et al.. (2019). Cytosolic phospholipase A2α modulates cell-matrix adhesion via the FAK/paxillin pathway in hepatocellular carcinoma. Cancer Biology and Medicine. 16(2). 377–377. 10 indexed citations
16.
Chiang, Kun‐Chun, Chun‐Nan Yeh, Ta‐Sen Yeh, et al.. (2018). MART-10, a 1α,25(OH)2D3 Analog, Potently Represses Metastasis of ER+ Breast Cancer Cells with VEGF-A Overexpression. Anticancer Research. 38(7). 3879–3887. 8 indexed citations
18.
Li, Hongyan, Jing Wu, Guoguang Ying, et al.. (2012). J-4. Anti-Cancer Drugs. 23(7). 691–697. 6 indexed citations
19.
Scott, Latanya M., Liwei Chen, Kenyon G. Daniel, et al.. (2010). Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs. Bioorganic & Medicinal Chemistry Letters. 21(2). 730–733. 37 indexed citations
20.
Chen, Liwei, Latanya M. Scott, Harshani R. Lawrence, et al.. (2010). Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112. Biochemical Pharmacology. 80(6). 801–810. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026